Molecular Diagnostics (MDx) Point of Care Market Overview: Driving Forces Behind Rapid Growth & Expansion

How Big is the Molecular Diagnostics (MDx) Point of Care Market?

The prevalence of diseases such as infectious diseases in developing countries as well as less developed countries is surging due to improving healthcare infrastructure and the preference of patients for efficient home care. Moreover, suitable government norms and extensive support are also helping in the market growth of MDx Point of Care market. According to MarkNtel Advisors’ research report titled “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”, the Global Molecular Diagnostics (MDx) Point of Care market is anticipated to grow at a CAGR of around 13% during 2020-25. However, a lack of arrangement with test results obtained from laboratories, strict & tedious approval policies are expected to restrain the market growth.

Market Statistics

Market Growth Rate (CAGR): 13% from 2020-2025

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/global-molecular-diagnostics-point-of-care-market.html

Molecular Diagnostics (MDx) Point of Care Market Segmentation:

The report has segmented the market into the following categories:

By Application

Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Others

By Technology

Isothermal Nucleic Acid Amplification Technology (INAAT)
Polymerase Chain Reaction (PCR)
- Digital PCR
- Real Time PCR
Others

By Product

Assays
Software
Services

By Test-Location

OTC (Over-the-counter)
POC (Point-of-care)

By End-User

Decentralized Labs
Hospitals
Homecare
Assisted Living Healthcare Facilities
Others

By Region

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/global-molecular-diagnostics-point-of-care-market.html

Competitive Landscape:

Abbott Laboratories
Mesa Biotech
Hologic, Inc.
QIAGEN N.V
F. Hoffmann-La Roche Ltd
DxNA LLC Group Ltd
Luminex Corporation
Siemens Healthineers
Johnson & Johnson
Roche Diagnostics
Danaher Corporation
EKF Diagnostics
Becton Dickison
Trinty Biotech
Quidel Corporation.

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address*

Other Report:

Key Highlights of the Report:

Market Performance (2020-2025)
Strategic Recommendations
Current, Historical and Future Market Trends
Market Drivers and Leading Competitor
SWOT Analysis
Structure of the Market
Comprehensive Mapping and Recent Advancement

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call + +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com